Human gene marker/therapy clinical protocols
Hum Gene Ther
.
2000 Apr 10;11(6):919-79.
doi: 10.1089/10430340050015536.
Authors
S A Rosenberg
,
R M Blaese
,
M K Brenner
,
A B Deisseroth
,
F D Ledley
,
M T Lotze
,
J M Wilson
,
G J Nabel
,
K Cornetta
,
J S Economou
,
S M Freeman
,
S R Riddell
,
M Brenner
,
E Oldfield
,
B Gansbacher
,
C Dunbar
,
R E Walker
,
F G Schuening
,
J A Roth
,
R G Crystal
,
M J Welsh
,
K Culver
,
H E Heslop
,
J Simons
,
R W Wilmott
,
R C Boucher
,
H F Siegler
,
J A Barranger
,
S Karlsson
,
D Kohn
,
J E Galpin
,
C Raffel
,
C Hesdorffer
,
J Ilan
,
P Cassileth
,
J O'Shaughnessy
,
L E Kun
,
T K Das
,
F Wong-Staal
,
R E Sobol
,
R Haubrich
,
M Sznol
,
J Rubin
,
E J Sorcher
,
J Rosenblatt
,
R Walker
,
K Brigham
,
N Vogelzang
,
E Hersh
,
S L Eck
PMID:
10779168
DOI:
10.1089/10430340050015536
No abstract available
MeSH terms
Clinical Protocols*
Genetic Markers
Genetic Therapy*
Humans
Substances
Genetic Markers